FDA Backs Down on Whoop’s Blood Pressure Feature After a Year-Long Fight
The FDA has dropped its enforcement action against Whoop over its Blood Pressure Insights feature, closing a year-long dispute that began with a 2025 warning letter and turned on new agency guidance about wellness-category wearables.